Appointment | December 22, 2021
Windlas Biotech appoints Shailendra Rastogi as CBO
He has over 22 years of experience in pharmaceutical sales & business development
He has over 22 years of experience in pharmaceutical sales & business development
It is a novel oral NLRP3 inflammasome inhibitor
Under this scheme, the company will make a committed investment in plant and machinery, get incentives on incremental sales of pharmaceutical products
SPARC will be eligible to receive an upfront payment, milestone payments and royalty on sales, in addition to 10% equity in Visiox
Serum has a capacity of 250-275 million whereas Bharat Biotech has a capacity of 50-60 million
The product will be commercialized from Unichem's Ghaziabad plant
This further adds to Biocon’s portfolio of vertically integrated complex drug products
The offline store launch will complement the E-commerce website in building a rich consumer shopping experience
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
The companies expect to manufacture over 80 million does of the Covid-19 vaccine in 2022
Subscribe To Our Newsletter & Stay Updated
